- THE MAGAZINE
Ceradyne also announced that it has submitted a proposal to the U.S. Marine Corps Systems Command (MARCORSYSCOM) in response to solicitation M67854-09-R-3025 for the procurement of enhanced combat helmets (ECH). The Marine Corps, now in conjunction with the U.S. Army PEO Soldier, intends to procure prototype combat helmets with the option to field production helmets to both services.
Ceradyne’s strategy is to combine its successful track record in body armor programs with the proprietary helmet-forming technologies of Diaphorm to create a world-class manufacturer of ECHs. Ceradyne-Diaphorm’s ECH will provide substantively increased levels of protection, utilizing high-volume repeatable manufacturing with reliable on-time delivery to support expedited procurements.
Diaphorm was founded in 2004 to conduct research and to manufacture and market ballistic helmets. Diaphorm currently manufactures polymer-based ballistic helmets for law enforcement, security and paramilitary markets. In addition to its patent portfolio, Diaphorm recently filed multiple patent applications around its helmet and plate manufacturing methods, and Ceradyne anticipates that there will be additional filings in the future. Diaphorm’s projected 2009 annual sales are estimated to be in the $3-4 million range for all of calendar year 2009. The contribution to Ceradyne’s estimated net income for the fiscal year ending December 31, 2009, from this acquisition is estimated to be immaterial.
“I am extremely pleased and excited over this acquisition,” said David Reed, Ceradyne vice president and president of North American Operations. “The acquisition paves the way for our entry into the protective combat and non-combat helmet market. This acquisition combines excellent technology with our ability to produce high-volume protective products for military applications. We’re also pleased to announce that yesterday we submitted the Ceradyne-Diaphorm response to the multi-year U.S. Marine/Army Enhanced Combat Helmet urgent and compelling substantial requirement.”
According to Christopher Meyers, head of CJM Investments Corp. and primary shareholder of Diaphorm Technologies, LLC, “We are thrilled to find the perfect home for Diaphorm Technologies. Ceradyne’s proven track record in providing quality personal protection solutions to the U.S. Military, coupled with Diaphorm’s market-leading thermoplastic forming technologies, creates a compelling force in the ballistic protection market.”
Management will conduct a conference call to discuss the Diaphorm acquisition at 8:00 a.m. PDT on Thursday, June 11, 2009. To participate in the teleconference, call (877) 717-3046 or (706) 634-6364 approximately 10 minutes prior to the start of the call. The teleconference will also be available live via the Internet at www.ceradyne.com or www.earnings.com. For those unable to attend, these sites will host an archive of the call and a playback will be available beginning at noon PDT on June 11 through noon PDT on June 13. The playback can be accessed by calling (800) 642-1687 or (706) 645-9291 and providing conference ID 14061368.